Health care investors NovaQuest, TripleTree Capital and Frist Cressey completed the investment in InformedDNA, a provider of genetics services. Financial terms were not disclosed. “Nearly a third of all genetic tests are ordered in error, negatively impacting patients, payers and providers. This investment will allow our organization to bring its technology-enabled genetic expertise to the people and companies that need it most to help enable better decision-making, improve outcomes, and lower costs,” David Nixon, InformedDNA CEO.